$433 Million is the total value of Eagle Health Investments LP's 27 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 17.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IQV | Buy | IQVIA HLDGS INC | $41,817,025 | +15.5% | 204,095 | +2.1% | 9.65% | +16.1% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $37,005,907 | +14.3% | 155,716 | -3.7% | 8.54% | +14.9% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $36,495,975 | +23.8% | 131,238 | -6.8% | 8.42% | +24.5% |
| NTRA | Buy | NATERA INC | $32,738,309 | +25.4% | 814,994 | +36.7% | 7.55% | +26.0% |
| OM | Sell | OUTSET MED INC | $31,516,124 | +59.8% | 1,220,609 | -1.4% | 7.27% | +60.6% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $28,718,831 | +26.0% | 108,230 | -11.0% | 6.62% | +26.6% |
| ILMN | Sell | ILLUMINA INC | $27,886,211 | -31.4% | 137,914 | -35.3% | 6.43% | -31.1% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $26,542,975 | +182.4% | 590,500 | +200.7% | 6.12% | +183.9% |
| INSP | Buy | INSPIRE MED SYS INC | $25,576,651 | +43.4% | 101,543 | +1.0% | 5.90% | +44.2% |
| DXCM | Sell | DEXCOM INC | $24,799,560 | +15.8% | 219,000 | -17.6% | 5.72% | +16.4% |
| ICLR | New | ICON PLC | $23,912,175 | – | 123,100 | +100.0% | 5.52% | – |
| ARGX | ARGENX SEsponsored adr | $22,843,449 | +7.3% | 60,300 | 0.0% | 5.27% | +7.9% | |
| SGEN | SEAGEN INC | $22,476,656 | -6.1% | 174,902 | 0.0% | 5.18% | -5.6% | |
| CTLT | New | CATALENT INC | $14,812,791 | – | 329,100 | +100.0% | 3.42% | – |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $9,726,003 | +228.4% | 437,911 | +18.9% | 2.24% | +230.0% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $7,515,050 | -19.4% | 267,630 | -18.8% | 1.73% | -19.0% |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $4,644,050 | -46.3% | 607,860 | -50.0% | 1.07% | -46.0% |
| AMWL | Sell | AMERICAN WELL CORPcl a | $3,947,960 | -69.7% | 1,395,039 | -61.6% | 0.91% | -69.6% |
| CMAX | CAREMAX INC | $2,608,856 | -48.5% | 714,755 | 0.0% | 0.60% | -48.2% | |
| GH | Sell | GUARDANT HEALTH INC | $1,810,432 | -77.9% | 66,560 | -56.2% | 0.42% | -77.7% |
| TXG | 10X GENOMICS INC | $1,792,848 | +28.0% | 49,200 | 0.0% | 0.41% | +28.6% | |
| BEAM | BEAM THERAPEUTICS INC | $1,130,279 | -17.9% | 28,900 | 0.0% | 0.26% | -17.4% | |
| OLK | OLINK HLDG ABsponsored ads | $1,015,200 | +108.9% | 40,000 | 0.0% | 0.23% | +108.9% | |
| ARVN | ARVINAS INC | $786,830 | -23.1% | 23,000 | 0.0% | 0.18% | -22.6% | |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $695,600 | +27.2% | 23,500 | 0.0% | 0.16% | +27.0% | |
| LYEL | LYELL IMMUNOPHARMA INC | $347,000 | -52.7% | 100,000 | 0.0% | 0.08% | -52.4% | |
| CANO | Sell | CANO HEALTH INC | $301,789 | -98.8% | 220,284 | -92.2% | 0.07% | -98.8% |
| AXNX | Exit | AXONICS INC | $0 | – | -110,560 | -100.0% | -1.79% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -377,965 | -100.0% | -4.76% | – |
| HUM | Exit | HUMANA INC | $0 | – | -59,091 | -100.0% | -6.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
| ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| NATERA INC | 12 | Q3 2023 | 8.5% |
| ARGENX SE | 12 | Q3 2023 | 7.0% |
| DEXCOM INC | 12 | Q3 2023 | 5.7% |
| OUTSET MED INC | 12 | Q3 2023 | 7.3% |
| AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
| ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.